Isomorphic Labs
Isomorphic Labs, founded in 2021, is an Alphabet subsidiary leveraging AI and computational methods, including their development of AlphaFold 3, to revolutionize drug discovery.
Services
Isomorphic Labs offers computational methods and AI-driven solutions to advance drug discovery. Central to their service offering is the AlphaFold Server, a powerful tool that assists non-commercial academic researchers in generating molecular complexes. By leveraging the capabilities of machine learning, Isomorphic Labs partners with pharmaceutical companies to tackle real-world drug design challenges, aiming to streamline the drug discovery process.
Founders
Founded in 2021, Isomorphic Labs builds on the breakthroughs achieved by Google DeepMind, particularly in the domain of protein structure prediction. As a part of the Alphabet family, Isomorphic Labs was established to apply artificial intelligence and computational methods to the complex field of drug discovery.
Products
One of the major products developed by Isomorphic Labs is AlphaFold 3, a transformative AI model capable of predicting the structure and interactions of biomolecular systems including proteins, DNA, RNA, and small molecule ligands. This innovation represents a significant leap forward in the understanding of molecular biology and its implications for drug discovery.
History
Isomorphic Labs was founded in 2021 with a focus on using AI and computational techniques to revolutionize drug discovery. The company emerged from the advances of AlphaFold, particularly in collaboration with Google DeepMind. As part of the Alphabet family, Isomorphic Labs leverages these achievements to address complex challenges in the field of molecular biology and pharmaceutical research.